{"transactions":[{"id":786811,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":48711,"kind":"person","name":"Hussain Abbas","position":1,"cik":"0001821956","reported_name":"Hussain Abbas","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2026-05-08T21:06:08.000Z","date":"2026-05-06","kind":"grant","planned":false,"acquired":true,"shares":8371,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this restricted stock unit award will vest in full on the earlier of May 6, 2027, or Moderna's next Annual Meeting of Shareholders, subject to the recipient's continued service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The shares subject to this restricted stock unit award will vest in full on the earlier of May 6, 2027, or Moderna's next Annual Meeting of Shareholders, subject to the recipient's continued service."}],"balance_after":8371,"derivative":{"underlying":"Common Stock","underlying_shares":8371},"source":{"system":"sec-edgar","filing":"0001682852-26-000095","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1682852/000168285226000095/form4.xml","form_type":"4"}},{"id":793854,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":48711,"kind":"person","name":"Hussain Abbas","position":1,"cik":"0001821956","reported_name":"Hussain Abbas","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2026-05-04T21:25:09.000Z","date":"2026-04-30","kind":"exercise","planned":true,"acquired":false,"shares":16233,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this restricted stock unit award vested in full on April 30, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The shares subject to this restricted stock unit award vested in full on April 30, 2026."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":16233},"source":{"system":"sec-edgar","filing":"0001682852-26-000070","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1682852/000168285226000070/form4.xml","form_type":"4"}},{"id":793853,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":48711,"kind":"person","name":"Hussain Abbas","position":1,"cik":"0001821956","reported_name":"Hussain Abbas","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-05-04T21:25:09.000Z","date":"2026-05-01","kind":"sale","planned":true,"acquired":false,"shares":5682,"price":46.63,"value":264951.66,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on September 5, 2025. The sale was made to generate proceeds to cover the tax liability incident to the vesting of restricted stock units."}],"balance_after":12066,"source":{"system":"sec-edgar","filing":"0001682852-26-000070","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1682852/000168285226000070/form4.xml","form_type":"4"}},{"id":793852,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":48711,"kind":"person","name":"Hussain Abbas","position":1,"cik":"0001821956","reported_name":"Hussain Abbas","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-05-04T21:25:09.000Z","date":"2026-04-30","kind":"exercise","planned":true,"acquired":true,"shares":16233,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":17748,"source":{"system":"sec-edgar","filing":"0001682852-26-000070","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1682852/000168285226000070/form4.xml","form_type":"4"}},{"id":972660,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":48711,"kind":"person","name":"Hussain Abbas","position":1,"cik":"0001821956","reported_name":"Hussain Abbas","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-12-11T21:16:32.000Z","date":"2025-12-09","kind":"sale","planned":true,"acquired":false,"shares":504,"price":27.6,"value":13910.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on September 5, 2025. The sale was made to generate proceeds to cover the tax liability incident to the vesting of restricted stock units."}],"balance_after":1515,"source":{"system":"sec-edgar","filing":"0001682852-25-000092","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1682852/000168285225000092/form4.xml","form_type":"4"}},{"id":1023290,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":48711,"kind":"person","name":"Hussain Abbas","position":1,"cik":"0001821956","reported_name":"Hussain Abbas","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2025-10-06T20:14:33.000Z","date":"2025-10-02","kind":"exercise","planned":false,"acquired":false,"shares":1439,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this restricted stock unit award vested in full on October 2, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The shares subject to this restricted stock unit award vested in full on October 2, 2025."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1439},"source":{"system":"sec-edgar","filing":"0001682852-25-000057","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1682852/000168285225000057/form4.xml","form_type":"4"}},{"id":1023289,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":48711,"kind":"person","name":"Hussain Abbas","position":1,"cik":"0001821956","reported_name":"Hussain Abbas","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-10-06T20:14:33.000Z","date":"2025-10-02","kind":"exercise","planned":false,"acquired":true,"shares":1439,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares subject to this restricted stock unit award vested in full on October 2, 2025."}],"balance_after":2019,"source":{"system":"sec-edgar","filing":"0001682852-25-000057","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1682852/000168285225000057/form4.xml","form_type":"4"}},{"id":1076038,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":48711,"kind":"person","name":"Hussain Abbas","position":1,"cik":"0001821956","reported_name":"Hussain Abbas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-08-05T00:53:40.000Z","date":"2025-07-31","kind":"exercise","planned":false,"acquired":false,"shares":12036,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On July 31, 2025, pursuant to the Transaction Agreement, dated as of March 13, 2025 (as amended, the \"Transaction Agreement\"), by and among Mallinckrodt plc (the \"Issuer\"), Endo, Inc. (\"Endo\") and Salvare Merger Sub LLC, the Issuer's wholly owned subsidiary (\"Merger Sub\"), the Merger Sub merged with and into Endo (the \"Business Combination\"), with Endo surviving the Business Combination as a wholly owned subsidiary of the Issuer. Upon the reporting person's resignation as a director of the Issuer, effective as of immediately following the Merger Effective Time (as defined in the Transaction Agreement), each restricted unit (the \"RSU\") held by the reporting person automatically settled in ordinary shares of the Issuer at one share per RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On July 31, 2025, pursuant to the Transaction Agreement, dated as of March 13, 2025 (as amended, the \"Transaction Agreement\"), by and among Mallinckrodt plc (the \"Issuer\"), Endo, Inc. (\"Endo\") and Salvare Merger Sub LLC, the Issuer's wholly owned subsidiary (\"Merger Sub\"), the Merger Sub merged with and into Endo (the \"Business Combination\"), with Endo surviving the Business Combination as a wholly owned subsidiary of the Issuer. Upon the reporting person's resignation as a director of the Issuer, effective as of immediately following the Merger Effective Time (as defined in the Transaction Agreement), each restricted unit (the \"RSU\") held by the reporting person automatically settled in ordinary shares of the Issuer at one share per RSU."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On July 31, 2025, pursuant to the Transaction Agreement, dated as of March 13, 2025 (as amended, the \"Transaction Agreement\"), by and among Mallinckrodt plc (the \"Issuer\"), Endo, Inc. (\"Endo\") and Salvare Merger Sub LLC, the Issuer's wholly owned subsidiary (\"Merger Sub\"), the Merger Sub merged with and into Endo (the \"Business Combination\"), with Endo surviving the Business Combination as a wholly owned subsidiary of the Issuer. Upon the reporting person's resignation as a director of the Issuer, effective as of immediately following the Merger Effective Time (as defined in the Transaction Agreement), each restricted unit (the \"RSU\") held by the reporting person automatically settled in ordinary shares of the Issuer at one share per RSU."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":12036},"source":{"system":"sec-edgar","filing":"0001104659-25-073798","document":"tm2522414-15_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1567892/000110465925073798/tm2522414-15_4seq1.xml","form_type":"4"}},{"id":1076037,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":48711,"kind":"person","name":"Hussain Abbas","position":1,"cik":"0001821956","reported_name":"Hussain Abbas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-08-05T00:53:40.000Z","date":"2025-07-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":9850,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The reporting person entered into an agreement with the Issuer pursuant to which the reporting person forfeited the right to receive 9,850 RSUs that would otherwise have vested in exchange for a payment from the Issuer to facilitate the reporting person's ability to satisfy certain tax obligations related to the RSUs scheduled to vest."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The number of RSUs forfeited is based on a percentage."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The reporting person entered into an agreement with the Issuer pursuant to which the reporting person forfeited the right to receive 9,850 RSUs that would otherwise have vested in exchange for a payment from the Issuer to facilitate the reporting person's ability to satisfy certain tax obligations related to the RSUs scheduled to vest."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The reporting person entered into an agreement with the Issuer pursuant to which the reporting person forfeited the right to receive 9,850 RSUs that would otherwise have vested in exchange for a payment from the Issuer to facilitate the reporting person's ability to satisfy certain tax obligations related to the RSUs scheduled to vest."}],"balance_after":12036,"derivative":{"underlying":"Ordinary Shares","underlying_shares":9850},"source":{"system":"sec-edgar","filing":"0001104659-25-073798","document":"tm2522414-15_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1567892/000110465925073798/tm2522414-15_4seq1.xml","form_type":"4"}},{"id":1076036,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":48711,"kind":"person","name":"Hussain Abbas","position":1,"cik":"0001821956","reported_name":"Hussain Abbas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-08-05T00:53:40.000Z","date":"2025-07-31","kind":"grant","planned":false,"acquired":true,"shares":16414,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Upon consummation of the Business Combination, each performance unit (\"PSU\") held by the reporting person automatically converted into an RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Upon consummation of the Business Combination, each performance unit (\"PSU\") held by the reporting person automatically converted into an RSU."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Upon consummation of the Business Combination, each performance unit (\"PSU\") held by the reporting person automatically converted into an RSU."}],"balance_after":21886,"derivative":{"underlying":"Ordinary Shares","underlying_shares":16414},"source":{"system":"sec-edgar","filing":"0001104659-25-073798","document":"tm2522414-15_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1567892/000110465925073798/tm2522414-15_4seq1.xml","form_type":"4"}},{"id":1076035,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":48711,"kind":"person","name":"Hussain Abbas","position":1,"cik":"0001821956","reported_name":"Hussain Abbas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-05T00:53:40.000Z","date":"2025-07-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":3433,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The number of ordinary shares withheld to satisfy tax withholding obligations arising out of the vesting of RSUs is based on a percentage and did not take into account any market value as the Issuer's ordinary shares are not listed or quoted on a recognized trading market."}],"balance_after":9783,"source":{"system":"sec-edgar","filing":"0001104659-25-073798","document":"tm2522414-15_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1567892/000110465925073798/tm2522414-15_4seq1.xml","form_type":"4"}},{"id":1076034,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":48711,"kind":"person","name":"Hussain Abbas","position":1,"cik":"0001821956","reported_name":"Hussain Abbas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-05T00:53:40.000Z","date":"2025-07-31","kind":"exercise","planned":false,"acquired":true,"shares":12036,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On July 31, 2025, pursuant to the Transaction Agreement, dated as of March 13, 2025 (as amended, the \"Transaction Agreement\"), by and among Mallinckrodt plc (the \"Issuer\"), Endo, Inc. (\"Endo\") and Salvare Merger Sub LLC, the Issuer's wholly owned subsidiary (\"Merger Sub\"), the Merger Sub merged with and into Endo (the \"Business Combination\"), with Endo surviving the Business Combination as a wholly owned subsidiary of the Issuer. Upon the reporting person's resignation as a director of the Issuer, effective as of immediately following the Merger Effective Time (as defined in the Transaction Agreement), each restricted unit (the \"RSU\") held by the reporting person automatically settled in ordinary shares of the Issuer at one share per RSU."}],"balance_after":13216,"source":{"system":"sec-edgar","filing":"0001104659-25-073798","document":"tm2522414-15_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1567892/000110465925073798/tm2522414-15_4seq1.xml","form_type":"4"}},{"id":1113340,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":48711,"kind":"person","name":"Hussain Abbas","position":1,"cik":"0001821956","reported_name":"Hussain Abbas","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-06-12T20:22:39.000Z","date":"2025-06-11","kind":"sale","planned":true,"acquired":false,"shares":312,"price":28,"value":8736.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2025.  The sale was made to generate proceeds to cover the tax liability incident to the vesting of restricted stock units."}],"balance_after":580,"source":{"system":"sec-edgar","filing":"0001127602-25-017354","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1682852/000112760225017354/form4.xml","form_type":"4"}},{"id":1162458,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":48711,"kind":"person","name":"Hussain Abbas","position":1,"cik":"0001821956","reported_name":"Hussain Abbas","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2025-05-01T20:29:10.000Z","date":"2025-04-30","kind":"grant","planned":false,"acquired":true,"shares":16233,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this restricted stock unit award will vest in full on the earlier of April 30, 2026, or Moderna's next Annual Meeting of Shareholders, subject to the recipient's continued service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The shares subject to this restricted stock unit award will vest in full on the earlier of April 30, 2026, or Moderna's next Annual Meeting of Shareholders, subject to the recipient's continued service."}],"balance_after":16233,"derivative":{"underlying":"Common Stock","underlying_shares":16233},"source":{"system":"sec-edgar","filing":"0001127602-25-012936","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1682852/000112760225012936/form4.xml","form_type":"4"}},{"id":1162457,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":48711,"kind":"person","name":"Hussain Abbas","position":1,"cik":"0001821956","reported_name":"Hussain Abbas","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2025-05-01T20:29:10.000Z","date":"2025-04-30","kind":"exercise","planned":false,"acquired":false,"shares":892,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this restricted stock unit award vested in full on April 30, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The shares subject to this restricted stock unit award vested in full on April 30, 2025."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":892},"source":{"system":"sec-edgar","filing":"0001127602-25-012936","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1682852/000112760225012936/form4.xml","form_type":"4"}},{"id":1162456,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":48711,"kind":"person","name":"Hussain Abbas","position":1,"cik":"0001821956","reported_name":"Hussain Abbas","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-05-01T20:29:10.000Z","date":"2025-04-30","kind":"exercise","planned":false,"acquired":true,"shares":892,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":892,"source":{"system":"sec-edgar","filing":"0001127602-25-012936","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1682852/000112760225012936/form4.xml","form_type":"4"}},{"id":1318308,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":48711,"kind":"person","name":"Hussain Abbas","position":1,"cik":"0001821956","reported_name":"Hussain Abbas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-01-02T22:06:45.000Z","date":"2025-01-01","kind":"exercise","planned":false,"acquired":false,"shares":1504,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") that was settled, was settled in ordinary shares of the issuer at one share per RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On February 19, 2024, the reporting person was granted 8,207 RSUs vesting ratably on each of the first three anniversaries of January 1, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On February 19, 2024, the reporting person was granted 8,207 RSUs vesting ratably on each of the first three anniversaries of January 1, 2024."}],"balance_after":5472,"derivative":{"underlying":"Ordinary Shares","underlying_shares":1504},"source":{"system":"sec-edgar","filing":"0001104659-25-000379","document":"tm2432211-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1567892/000110465925000379/tm2432211-6_4seq1.xml","form_type":"4"}},{"id":1318307,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":48711,"kind":"person","name":"Hussain Abbas","position":1,"cik":"0001821956","reported_name":"Hussain Abbas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-01-02T22:06:45.000Z","date":"2025-01-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1231,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The reporting person entered into an agreement with the issuer pursuant to which the reporting person forfeited the right to receive 1,231 RSUs that would otherwise have vested in exchange for a payment from the issuer to facilitate the reporting person's ability to satisfy certain tax obligations related to the RSUs scheduled to vest."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The number of RSUs forfeited is based on a percentage."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On February 19, 2024, the reporting person was granted 8,207 RSUs vesting ratably on each of the first three anniversaries of January 1, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On February 19, 2024, the reporting person was granted 8,207 RSUs vesting ratably on each of the first three anniversaries of January 1, 2024."}],"balance_after":6976,"derivative":{"underlying":"Ordinary Shares","underlying_shares":1231},"source":{"system":"sec-edgar","filing":"0001104659-25-000379","document":"tm2432211-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1567892/000110465925000379/tm2432211-6_4seq1.xml","form_type":"4"}},{"id":1318306,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":48711,"kind":"person","name":"Hussain Abbas","position":1,"cik":"0001821956","reported_name":"Hussain Abbas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-01-02T22:06:45.000Z","date":"2025-01-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":324,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The number of ordinary shares withheld to satisfy tax withholding obligations arising out the vesting of RSUs is based on a percentage and did not take into account any market value as the issuer's ordinary shares are not listed or quoted on a recognized trading market."}],"balance_after":1180,"source":{"system":"sec-edgar","filing":"0001104659-25-000379","document":"tm2432211-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1567892/000110465925000379/tm2432211-6_4seq1.xml","form_type":"4"}},{"id":1318305,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":48711,"kind":"person","name":"Hussain Abbas","position":1,"cik":"0001821956","reported_name":"Hussain Abbas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-01-02T22:06:45.000Z","date":"2025-01-01","kind":"exercise","planned":false,"acquired":true,"shares":1504,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (the \"RSU\") that was settled, was settled in ordinary shares of the issuer at one share per RSU."}],"balance_after":1504,"source":{"system":"sec-edgar","filing":"0001104659-25-000379","document":"tm2432211-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1567892/000110465925000379/tm2432211-6_4seq1.xml","form_type":"4"}},{"id":1390774,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":48711,"kind":"person","name":"Hussain Abbas","position":1,"cik":"0001821956","reported_name":"Hussain Abbas","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2024-10-04T12:52:56.000Z","date":"2024-10-02","kind":"grant","planned":false,"acquired":true,"shares":892,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares subject to this restricted stock unit award will vest in full on the earlier of May 6, 2025, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The shares subject to this restricted stock unit award will vest in full on the earlier of May 6, 2025, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service."}],"balance_after":892,"derivative":{"underlying":"Common Stock","underlying_shares":892},"source":{"system":"sec-edgar","filing":"0001127602-24-025227","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1682852/000112760224025227/form4.xml","form_type":"4"}},{"id":1390773,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":48711,"kind":"person","name":"Hussain Abbas","position":1,"cik":"0001821956","reported_name":"Hussain Abbas","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2024-10-04T12:52:56.000Z","date":"2024-10-02","kind":"grant","planned":false,"acquired":true,"shares":1439,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to this restricted stock unit award will vest in full on October 2, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The shares subject to this restricted stock unit award will vest in full on October 2, 2025."}],"balance_after":1439,"derivative":{"underlying":"Common Stock","underlying_shares":1439},"source":{"system":"sec-edgar","filing":"0001127602-24-025227","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1682852/000112760224025227/form4.xml","form_type":"4"}},{"id":1390772,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":48711,"kind":"person","name":"Hussain Abbas","position":1,"cik":"0001821956","reported_name":"Hussain Abbas","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-10-04T12:52:56.000Z","date":"2024-10-02","kind":"grant","planned":false,"acquired":true,"shares":5100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option will become fully vested and exercisable on the earlier of May 6, 2025, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service."}],"balance_after":5100,"derivative":{"exercise_price":63.16,"expiration_date":"2034-10-02","underlying":"Common Stock","underlying_shares":5100},"source":{"system":"sec-edgar","filing":"0001127602-24-025227","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1682852/000112760224025227/form4.xml","form_type":"4"}},{"id":1390771,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":48711,"kind":"person","name":"Hussain Abbas","position":1,"cik":"0001821956","reported_name":"Hussain Abbas","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-10-04T12:52:56.000Z","date":"2024-10-02","kind":"grant","planned":false,"acquired":true,"shares":8093,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will become fully vested and exercisable on October 2, 2025."}],"balance_after":8093,"derivative":{"exercise_price":63.16,"expiration_date":"2034-10-02","underlying":"Common Stock","underlying_shares":8093},"source":{"system":"sec-edgar","filing":"0001127602-24-025227","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1682852/000112760224025227/form4.xml","form_type":"4"}},{"id":1632664,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":48711,"kind":"person","name":"Hussain Abbas","position":1,"cik":"0001821956","reported_name":"Hussain Abbas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-02-20T21:13:12.000Z","date":"2024-02-19","kind":"grant","planned":false,"acquired":false,"shares":8207,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon vesting, each restricted stock unit (the \"RSU\") will be settled in ordinary shares of the issuer at one share per RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs will vest ratably on each of the first three anniversaries of January 1, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs will vest ratably on each of the first three anniversaries of January 1, 2024."}],"balance_after":8207,"derivative":{"underlying":"Ordinary Shares","underlying_shares":8207},"source":{"system":"sec-edgar","filing":"0001104659-24-025522","document":"tm245307-10_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1567892/000110465924025522/tm245307-10_4seq1.xml","form_type":"4"}},{"id":2667204,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":48711,"kind":"person","name":"Hussain Abbas","position":1,"cik":"0001821956","reported_name":"Hussain Abbas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2021-06-16T12:18:22.000Z","date":"2021-06-14","kind":"grant","acquired":true,"shares":14479,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted share units were granted on June 14, 2021 and vest on June 14, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted share units were granted on June 14, 2021 and vest on June 14, 2022."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":14479,"derivative":{"underlying":"Ordinary Shares","underlying_shares":14479},"source":{"system":"sec-edgar","filing":"0001209191-21-040809","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121040809/doc4.xml","form_type":"4"}},{"id":3040251,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":48711,"kind":"person","name":"Hussain Abbas","position":1,"cik":"0001821956","reported_name":"Hussain Abbas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2020-09-03T20:11:00.000Z","date":"2020-09-02","kind":"grant","acquired":true,"shares":13050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted share units were granted on September 2, 2020 and vest on September 2, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted share units were granted on September 2, 2020 and vest on September 2, 2021."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":13050,"derivative":{"underlying":"Ordinary Shares","underlying_shares":13050},"source":{"system":"sec-edgar","filing":"0001209191-20-049375","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919120049375/doc4.xml","form_type":"4"}}]}